• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌全乳照射后大分割加量放疗:慢性毒性结果与美容效果

Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis.

作者信息

Sanz J, Rodríguez N, Foro P, Dengra J, Reig A, Pérez P, Membrive I, Ortiz A, Codinach M, Algara M

机构信息

Radiation Oncology Department, Hospital de l'Esperança, Parc de Salut Mar, Avinguda Sant Josep de la Muntanya 12, 08024, Barcelona, Spain.

Radiation Oncology Research Group, Institut Municipal d'Investigació Médica (IMIM), Doctor Aiguader, 88, 08003, Barcelona, Spain.

出版信息

Clin Transl Oncol. 2017 Apr;19(4):464-469. doi: 10.1007/s12094-016-1548-3. Epub 2016 Sep 21.

DOI:10.1007/s12094-016-1548-3
PMID:27655367
Abstract

PURPOSE

To evaluate the impact of hypofractionated boost after hypofractionated whole breast irradiation in breast carcinoma.

METHODS AND MATERIALS

Patients after breast conservative surgery were treated all time with hypofractionation of 2.67 Gy/day. Whole breast dose was 40.05 Gy followed in case of risk of local relapse by a boost of 16.02 Gy or 8.01 Gy. Acute and chronic toxicity results were evaluated including cosmetic software-assisted assessment and objective evaluation of fibrosis parameters (elasticity and hydration) by means of a skin tester.

RESULTS

A total of 362 patients were evaluated. Acute toxicities comprised grade 1 dermatitis in 48.1 %, grade 2 in 44.5 % and grade 3 in 17 patients 4.7 %, respectively. After a median follow-up of 4.5 years, in 308 cases (86.6 %) there was no chronic skin or subcutaneous changes. In the first consecutive 50 patients, measures with skin tester showed no statistical differences in parameters for skin and subcutaneous fibrosis. Cosmetic results were considered excellent and good in 26 and 62 %, respectively.

CONCLUSIONS

Boost to tumour bed with hypofractionated doses is well tolerated and acute and chronic toxicities are mild with good cosmetic results. Objective systems are encouraging methods to assess skin quality and cosmesis.

摘要

目的

评估乳腺癌大分割全乳照射后大分割推量照射的影响。

方法和材料

保乳手术后的患者均接受每日2.67 Gy的大分割治疗。全乳剂量为40.05 Gy,若有局部复发风险,则追加16.02 Gy或8.01 Gy的推量照射。评估急性和慢性毒性结果,包括使用美容软件辅助评估以及通过皮肤测试仪对纤维化参数(弹性和水合作用)进行客观评估。

结果

共评估了362例患者。急性毒性反应中,48.1%为1级皮炎,44.5%为2级,17例(4.7%)为3级。中位随访4.5年后,308例(86.6%)无慢性皮肤或皮下改变。在最初连续的50例患者中,皮肤测试仪测量结果显示皮肤和皮下纤维化参数无统计学差异。美容效果方面,分别有26%和62%被评为优秀和良好。

结论

大分割剂量对瘤床的推量照射耐受性良好,急慢性毒性反应轻微,美容效果良好。客观评估系统是评估皮肤质量和美容效果很有前景的方法。

相似文献

1
Hypofractionated boost after whole breast irradiation in breast carcinoma: chronic toxicity results and cosmesis.乳腺癌全乳照射后大分割加量放疗:慢性毒性结果与美容效果
Clin Transl Oncol. 2017 Apr;19(4):464-469. doi: 10.1007/s12094-016-1548-3. Epub 2016 Sep 21.
2
Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.0至IIIa期乳腺癌女性短疗程大分割放疗联合推量放疗:一项2期试验
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):118-125. doi: 10.1016/j.ijrobp.2015.09.011. Epub 2015 Sep 16.
3
Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.印度东部一家三级护理中心的乳腺癌大分割放疗——初步结果
Asian Pac J Cancer Prev. 2014;15(6):2505-10. doi: 10.7314/apjcp.2014.15.6.2505.
4
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.采用容积调强弧形治疗技术进行乳腺癌辅助放疗的Hypofractionated 同期整合推量的 I- II 期研究:50 例治疗的可行性和早期毒性结果报告。
Radiat Oncol. 2012 Aug 28;7:145. doi: 10.1186/1748-717X-7-145.
5
Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer.早期乳腺癌大分割全乳照射后的皮肤毒性和美容效果
J Med Assoc Thai. 2012 Feb;95(2):229-40.
6
Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.大分割全乳放疗的毒性和美容效果:预测性临床和剂量学因素
Radiat Oncol. 2014 Apr 24;9:97. doi: 10.1186/1748-717X-9-97.
7
Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.早期乳腺癌瘤床推量加部分乳腺低分割照射的疗效分析。
Clin Breast Cancer. 2017 Dec;17(8):638-643. doi: 10.1016/j.clbc.2017.05.010. Epub 2017 May 25.
8
5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.在乳腺癌局部复发高危患者中,保乳治疗后采用脉冲剂量率近距离放疗作为补充治疗的5年结果。
Strahlenther Onkol. 2002 Nov;178(11):607-14. doi: 10.1007/s00066-002-0977-9.
9
Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.保乳术后加速缩野适形放疗联合同期光子推量治疗早期乳腺癌的前瞻性研究:463 例患者的结果分析
Breast J. 2011 Nov-Dec;17(6):586-93. doi: 10.1111/j.1524-4741.2011.01159.x. Epub 2011 Sep 21.
10
Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.大分割乳腺放疗:疗程更短,毒性更低。
Clin Breast Cancer. 2016 Aug;16(4):262-8. doi: 10.1016/j.clbc.2015.09.012. Epub 2015 Sep 25.

引用本文的文献

1
Tumor Bed Boost Radiotherapy in the Conservative Treatment of Breast Cancer: A Review of Intra-Operative Techniques and Outcomes.乳腺癌保守治疗中的瘤床加量放疗:术中技术与结果综述
Cancers (Basel). 2023 Aug 8;15(16):4025. doi: 10.3390/cancers15164025.
2
Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients.每周一次的老年乳腺癌Hypofractionated 放射治疗:486 例患者的疗效和耐受性。
Biomed Res Int. 2018 Mar 15;2018:8321871. doi: 10.1155/2018/8321871. eCollection 2018.

本文引用的文献

1
Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial.与 Young Boost Breast Trial 中患者报告的美容结果相关的因素。
Radiother Oncol. 2016 Jul;120(1):107-13. doi: 10.1016/j.radonc.2016.04.017. Epub 2016 May 28.
2
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.保乳手术后早期乳腺癌患者行全乳放疗或加量放疗:一项随机 3 期临床试验 20 年随访结果
Lancet Oncol. 2015 Jan;16(1):47-56. doi: 10.1016/S1470-2045(14)71156-8. Epub 2014 Dec 9.
3
Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
美国保乳手术后采用低分割与常规全乳照射的摄取率和成本:2008-2013 年。
JAMA. 2014 Dec 17;312(23):2542-50. doi: 10.1001/jama.2014.16616.
4
Accelerated hypofractionated breast radiotherapy: FAQs (frequently asked questions) and facts.加速分割乳腺放疗:常见问题及事实
Breast. 2014 Aug;23(4):299-309. doi: 10.1016/j.breast.2014.01.011. Epub 2014 Feb 12.
5
Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.三维适形外照射放疗行加速部分乳腺照射的 5 年结果、美容效果和毒性。
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1051-7. doi: 10.1016/j.ijrobp.2013.08.046. Epub 2013 Oct 22.
6
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.英国乳腺癌放射治疗标准化(START)试验——早期乳腺癌放射治疗的分割方案优化:两项随机对照临床试验的 10 年随访结果。
Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.
7
Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.早期乳腺癌患者大分割与常规分割全乳照射的比较:一项针对1098例患者的单机构研究
Breast Cancer. 2014 Jul;21(4):402-8. doi: 10.1007/s12282-012-0406-6. Epub 2012 Sep 12.
8
Ten-year results of a phase II study with a single fraction of high-dose-rate brachytherapy (FAST-boost) after whole breast irradiation in invasive breast carcinoma.一项 II 期研究的 10 年结果,该研究在浸润性乳腺癌全乳放疗后单次高剂量率近距离放疗(FAST-boost)。
Clin Transl Oncol. 2012 Feb;14(2):109-15. doi: 10.1007/s12094-012-0769-3.
9
Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy--a feasibility and toxicity study.全乳分 fractions 放疗中同期强度调节 boost 的可行性及毒性研究。
Radiother Oncol. 2012 Jan;102(1):89-95. doi: 10.1016/j.radonc.2011.10.015. Epub 2011 Nov 21.
10
Is α/β for breast cancer really low?乳腺癌的α/β 真的低吗?
Radiother Oncol. 2011 Aug;100(2):282-8. doi: 10.1016/j.radonc.2011.01.010. Epub 2011 Feb 28.